Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseскороОткрытый API экосистемы
Латиница
Русский
Статья

Drug delivery and anticancer activity of biosynthesised mesoporous Fe <sub>2</sub> O <sub>3</sub> nanoparticles

Firoozeh Abolhasani ZadehDepartment of Surgery Faculty of Medicine Kerman University of Medical Sciences Kerman IranSaade Abdalkareem JasimMedical Laboratory Techniques Department Al‐maarif University College Al‐anbar‐Ramadi IraqN. E. AtakhanovaDepartment of Oncology and Radiology Tashkent Medical Academy Tashkent UzbekistanHasan Sh. MajdiMohammed Abed JawadAl‐Nisour University College Baghdad IraqMohammed Khudair HasanDepartment of Pharmacy Al‐Manara College of Medical Sciences Missan IraqFariba BorhaniMedical Ethics and Law Research Center Shahid Beheshti University of Medical Sciences Tehran IranMehrdad KhatamiDepartment of Medical Biotechnology Faculty of Medical Sciences Tarbiat Modares University Tehran Iran
IET Nanobiotechnologyjournal2022en
ABI

Аннотация

Abstract Mesoporous magnetic nanoparticles of haematite were synthesised using plant extracts according to bioethics principles. The structural, physical and chemical properties of mesoporous Fe 2 O 3 nanoparticles synthesised with the green chemistry approach were evaluated by XRD, SEM, EDAX, BET, VSM and HRTEM analysis. Then, their toxicity against normal HUVECs and MCF7 cancer cells was evaluated by MTT assay for 48 h. These biogenic mesoporous magnetic nanoparticles have over 71% of doxorubicin loading efficiency, resulting in a 50% reduction of cancer cells at a 0.5 μg.ml −1 concentration. Therefore, it is suggested that mesoporous magnetic nanoparticles be used as a multifunctional agent in medicine (therapeutic‐diagnostic). The produced mesoporous magnetic nanoparticles with its inherent structural properties such as polygonal structure (increasing surface area to particle volume) and porosity with large pore volume became a suitable substrate for loading the anti‐cancer drug doxorubicin.

Темы

Идентификаторы

Цитирования и источники

Показатели — AkademScholar · Скоро